PHARMA SECTOR

Global Female Contraception Drug Market 2017 By Sales and Revenue Analysis Report

Press Release   •   Jan 02, 2018 02:56 EST

In this report, the Global Female Contraception Drug Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Click Here To Get Request Sample: http://globalqyresearch.com/download-sample/327561

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Female Contraception Drug in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Global Female Contraception Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer AG
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
AG-890
Amphora
BAY-1007626
Drospirenone
Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Clinic
Hospital
Homecare

If you have any special requirements, please let us know and we will offer you the report as you want.

Would like to place an order or any question, please feel free to Contact: Jay@globalqyresearch.com or Sales@globalqyresearch.com

Table of Contents

Global Female Contraception Drug Market Research Report 2017
1 Female Contraception Drug Market Overview
1.1 Product Overview and Scope of Female Contraception Drug
1.2 Female Contraception Drug Segment by Type (Product Category)
1.2.1 Global Female Contraception Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Female Contraception Drug Production Market Share by Type (Product Category) in 2016
1.2.3 AG-890
1.2.4 Amphora
1.2.5 BAY-1007626
1.2.6 Drospirenone
1.2.7 Others
1.3 Global Female Contraception Drug Segment by Application
1.3.1 Female Contraception Drug Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Global Female Contraception Drug Market by Region (2012-2022)
1.4.1 Global Female Contraception Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Female Contraception Drug (2012-2022)
1.5.1 Global Female Contraception Drug Revenue Status and Outlook (2012-2022)
1.5.2 Global Female Contraception Drug Capacity, Production Status and Outlook (2012-2022)

2 Global Female Contraception Drug Market Competition by Manufacturers
2.1 Global Female Contraception Drug Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Female Contraception Drug Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Female Contraception Drug Production and Share by Manufacturers (2012-2017)
2.2 Global Female Contraception Drug Revenue and Share by Manufacturers (2012-2017)
2.3 Global Female Contraception Drug Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Female Contraception Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Female Contraception Drug Market Competitive Situation and Trends
2.5.1 Female Contraception Drug Market Concentration Rate
2.5.2 Female Contraception Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Female Contraception Drug Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Female Contraception Drug Capacity and Market Share by Region (2012-2017)
3.2 Global Female Contraception Drug Production and Market Share by Region (2012-2017)
3.3 Global Female Contraception Drug Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Female Contraception Drug Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Female Contraception Drug Consumption by Region (2012-2017)
4.2 North America Female Contraception Drug Production, Consumption, Export, Import (2012-2017)
4.3 Europe Female Contraception Drug Production, Consumption, Export, Import (2012-2017)
4.4 China Female Contraception Drug Production, Consumption, Export, Import (2012-2017)
4.5 Japan Female Contraception Drug Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Female Contraception Drug Production, Consumption, Export, Import (2012-2017)
4.7 India Female Contraception Drug Production, Consumption, Export, Import (2012-2017)

5 Global Female Contraception Drug Production, Revenue (Value), Price Trend by Type
5.1 Global Female Contraception Drug Production and Market Share by Type (2012-2017)
5.2 Global Female Contraception Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Female Contraception Drug Price by Type (2012-2017)
5.4 Global Female Contraception Drug Production Growth by Type (2012-2017)

6 Global Female Contraception Drug Market Analysis by Application
6.1 Global Female Contraception Drug Consumption and Market Share by Application (2012-2017)
6.2 Global Female Contraception Drug Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Female Contraception Drug Manufacturers Profiles/Analysis
7.1 Addex Therapeutics Ltd
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Female Contraception Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Addex Therapeutics Ltd Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Agile Therapeutics Inc
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Female Contraception Drug Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Agile Therapeutics Inc Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Bayer AG
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Female Contraception Drug Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Bayer AG Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Evofem Inc
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Female Contraception Drug Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Evofem Inc Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Hervana Ltd
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Female Contraception Drug Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Hervana Ltd Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Mithra Pharmaceuticals SA
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Female Contraception Drug Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Orbis Biosciences Inc
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Female Contraception Drug Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Orbis Biosciences Inc Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Teva Pharmaceutical Industries Ltd
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Female Contraception Drug Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Viramal Ltd
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Female Contraception Drug Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Viramal Ltd Female Contraception Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview

8 Female Contraception Drug Manufacturing Cost Analysis
8.1 Female Contraception Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Female Contraception Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Female Contraception Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Female Contraception Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Female Contraception Drug Market Forecast (2017-2022)
12.1 Global Female Contraception Drug Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Female Contraception Drug Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Female Contraception Drug Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Female Contraception Drug Price and Trend Forecast (2017-2022)
12.2 Global Female Contraception Drug Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Female Contraception Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Female Contraception Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Female Contraception Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Female Contraception Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Female Contraception Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Female Contraception Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Female Contraception Drug Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Female Contraception Drug Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer

To Purchase this Premium Report: http://globalqyresearch.com/checkout-form/0/327561

About Us:

Global QYResearch is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Browse Our Pharma Blog:http://pharmainvestmentnews.com/

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London,

E182AN, United Kingdom

Contact: +44 20 3239 2407